EB-1020 (Centanafadine) low dose

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

EB-1020 (Centanafadine) low dose
Treatment and conditionWhere it standsTrials
EB-1020 (Centanafadine) low dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1